Cargando…

Successful treatment of hairy cell leukemia variant with obinutuzumab

Detalles Bibliográficos
Autores principales: Al-Sarayfi, Diana, Meeuwes, Freek O., Munnink, Thijs Oude, Plattel, Wouter, Rosati, Stefano, Matutes, Estella, Nijland, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810450/
https://www.ncbi.nlm.nih.gov/pubmed/34086065
http://dx.doi.org/10.1007/s00277-021-04559-z
_version_ 1784644255771262976
author Al-Sarayfi, Diana
Meeuwes, Freek O.
Munnink, Thijs Oude
Plattel, Wouter
Rosati, Stefano
Matutes, Estella
Nijland, Marcel
author_facet Al-Sarayfi, Diana
Meeuwes, Freek O.
Munnink, Thijs Oude
Plattel, Wouter
Rosati, Stefano
Matutes, Estella
Nijland, Marcel
author_sort Al-Sarayfi, Diana
collection PubMed
description
format Online
Article
Text
id pubmed-8810450
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88104502022-02-09 Successful treatment of hairy cell leukemia variant with obinutuzumab Al-Sarayfi, Diana Meeuwes, Freek O. Munnink, Thijs Oude Plattel, Wouter Rosati, Stefano Matutes, Estella Nijland, Marcel Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2021-06-04 2022 /pmc/articles/PMC8810450/ /pubmed/34086065 http://dx.doi.org/10.1007/s00277-021-04559-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Al-Sarayfi, Diana
Meeuwes, Freek O.
Munnink, Thijs Oude
Plattel, Wouter
Rosati, Stefano
Matutes, Estella
Nijland, Marcel
Successful treatment of hairy cell leukemia variant with obinutuzumab
title Successful treatment of hairy cell leukemia variant with obinutuzumab
title_full Successful treatment of hairy cell leukemia variant with obinutuzumab
title_fullStr Successful treatment of hairy cell leukemia variant with obinutuzumab
title_full_unstemmed Successful treatment of hairy cell leukemia variant with obinutuzumab
title_short Successful treatment of hairy cell leukemia variant with obinutuzumab
title_sort successful treatment of hairy cell leukemia variant with obinutuzumab
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810450/
https://www.ncbi.nlm.nih.gov/pubmed/34086065
http://dx.doi.org/10.1007/s00277-021-04559-z
work_keys_str_mv AT alsarayfidiana successfultreatmentofhairycellleukemiavariantwithobinutuzumab
AT meeuwesfreeko successfultreatmentofhairycellleukemiavariantwithobinutuzumab
AT munninkthijsoude successfultreatmentofhairycellleukemiavariantwithobinutuzumab
AT plattelwouter successfultreatmentofhairycellleukemiavariantwithobinutuzumab
AT rosatistefano successfultreatmentofhairycellleukemiavariantwithobinutuzumab
AT matutesestella successfultreatmentofhairycellleukemiavariantwithobinutuzumab
AT nijlandmarcel successfultreatmentofhairycellleukemiavariantwithobinutuzumab